• Home
  • Science
    • Atrial Fibrillation
    • Budiodarone
  • Publications
  • Team
  • News
    • XYRA Announces Issuance of US Patent to
    • XYRA Announces the Issuance of a Fifth N
    • XYRA Announces FDA Label Guidance for Ma
    • XYRA Announces Successful FDA End of Pha

Publications

Ezekowitz MD, Nagarakanti R, Lubinski A, Bandman O, Canafax D, Ellis DJ, et al. A randomized trial of budiodarone in paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 2012;34(1):1-9 Arya A, Silberbauer J, Teichman SL, Milner P, Sulke N, Camm AJ. A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology. EP Europace. 2009;11(4):458-64
Contact
press@xyra.us
Find out more
Thank you!
Error
Bad respond
Copyright © 2025 XYRA LLC.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Cookies and Privacy Policy.

Your Cookie Settings

We use cookies to enable essential functionality on our website and analyze website traffic. For more information, read our our Cookies and Privacy Policy below.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites.

Analytics

These cookies collect information that is used in aggregate and in an anonymized form to help us understand how our website is being used and how effectively our site is performing.